Base of the pyramid project
Active Since: 2010
Multi-Company Partnership
Contributing to SDGs…
An initiative to facilitate access to diabetes care for the working poor in low- and middle-income countries.
MEMBER COMPANIES
-
Novo Nordisk
Company Profile -
Roche
Company Profile
PARTNER ORGANISATIONS
-
Academia or research institute
University College London
-
Government
Kenya Ministry of Health
Royal Danish Embassy in Kenya
-
Hospitals/Health Facilities
Local hospitals and health facilities
-
Local NGOs
Mission for Essential Drugs and Supplies (MEDS)
Mombasa and Kakamega County
the Kenya Defeat Diabetes Association
Kenya Conference of Catholic Bishops and Christian Health Association Kenya (faith-based organisations)
-
Pharma (Non-IPFMA Member)
Phillips Pharmaceuticals Ltd
Palb Pharmaceuticals
Objectives
- Increased awareness of diabetes
- Early diagnosis of diabetes
- Access to quality care by trained health care professionals
- Stable and affordable supply of insulin
- Improved self-management through patient education
Around a half of the world’s population lacks access to essential health services including essential medicines like insulin.1,2 This is especially an issue in low- and middle income countries which also is home to eighty percent of people living with diabetes today.2 However, diabetes and other non-communicable diseases continue to be under prioritised in development assistance for health (DAH).3
The Base of the Pyramid project targets the more than one billion people globally with low incomes, the working poor, who have difficulties accessing health services. These people have some disposable income and could contribute to financing their own treatment.
The purpose of the Base of the Pyramid project is to create shared value by developing scalable, sustainable and profitable solutions that increase access to diabetes care for the working poor living in low- and middle-income countries as well as provide value to the business of Novo Nordisk.
References
1 Tracking universal health coverage: 2017 global monitoring report. World Health Organization and International Bank for Reconstruction and Development / The World Bank; 2017. Licence: CC BY-NC-SA 3.0 IGO.
2 International Diabetes Federation. IDF Diabetes Atlas, 8th edn. Brussels, Belgium: International Diabetes Federation, 2017.
3 IHME. Financing Global Health 2015: Development assistance steady on the path to new Global Goals. Seattle, WA: Institute for Health Metrics and Evaluation (IHME). 2016.
SDGs THE PARTNERSHIP CONTRIBUTES TO
SDG 3: Good Health and Wellbeing
- 3.4: NCDs (including mental health)
SDG 9: Industry Innovation and Infrastructure
SDG 10: Reduced Inequalities
SDG 17: Partnerships for the Goals
RESULTS & MILESTONES
The project is currently being implemented in Nigeria, Kenya, Ghana and Senegal.
Patients reached in 2018:
- Kenya: 19,500
- Nigeria: 5,000
- Ghana: 5,564
- Senegal: 1,200
External impact report of the project in Kenya by UCL
ADDITIONAL INFORMATION
Geographic Reach
Africa
- Ghana
- Kenya
- Nigeria
- Senegal
Disease Area
Non-communicable Diseases
- Diabetes
- General Noncommunicable Disease Care (Health System)
- Type 1
- General
- Type 2